Hologic Inc (HOLX)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Hologic Inc (HOLX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011735
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:70
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hologic Inc (Hologic) is a medical device company. It develops, manufactures and supplies diagnostic products, medical imaging systems and surgical products. The company offers diagnostic products to aid in the diagnosis of human diseases and screen donated human blood; a broad portfolio of breast imaging and related products and accessories; gynecology surgical products including endometrial ablation system and hysteroscopic tissue removal system; and skeletal health products including dual-energy X-ray bone densitometry systems and mini C-arm imaging products. The company offers these solutions to surgeons, hospitals, clinical laboratories and healthcare providers. Hologic offers its products and services through a network of direct sales and service forces and through independent distributors and sales representatives. The company operates in the Americas, Europe and Asia-Pacific. Hologic is headquartered in Marlborough, Massachusetts, the US.

Hologic Inc (HOLX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Hologic Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Hologic Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Hologic Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Hologic Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Hologic Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Hologic Inc, Medical Equipment, Deal Details 12
Asset Purchase 12
Hologic Acquires PCA3 Assets from DiagnoCure for USD4.7 Million 12
Private Equity 13
Percipient Capital Completes Management Buyout Of Elucigene Diagnostics 13
Partnerships 14
MeVis Medical Enters into Licensing Agreement with Hologic 14
Microsulis Medical Enters Into Licensing Agreement With Hologic 15
Hologic Enters into Development and Distribution Agreement with Clarius Mobile Health 16
Seegene Enters into Agreement with Hologic 17
U.S. Department of Health and Human Services Enters into Agreement with Hologic 18
Bovie Medical Enters into Agreement with Hologic 19
Metamark Genetics Enters into Distribution Agreement with Hologic 20
Metamark Genetics Plans to Enter into Co-Development Agreement with Hologic 21
Medimaps Enters into Distribution Agreement with Hologic for TBS iNsight 22
Quest Diagnostics Enters Into Co-Development Agreement With Hologic 23
Debt Offering 24
Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 24
Hologic Raises USD1 Billion in Private Placement of 5.25% Notes Due 2022 25
Hologic Completes Private Placement Of Senior Notes Due 2020 For US$1 Billion 26
Asset Transactions 27
Grifols Acquires Nucleic Acid Testing Donor Screening Unit from Hologic for USD1.85 Billion 27
Immucor Completes Acquisition Of Lifecodes Business Of Hologic For US$95 Million 29
Atossa Genetics Acquires Rights to Microcatheter System from Hologic 31
Acquisition 32
Hologic Acquires Cynosure in Tender Offer 32
Hologic Completes Acquisition Of Gen-Probe For US$3.7 Billion 34
Hologic Acquires Beijing Healthcome For Up To US$17 Million 36
Hologic Acquires TCT International 37
Hologic Acquires Interlace Medical 38
Hologic Inc – Key Competitors 40
Hologic Inc – Key Employees 41
Hologic Inc – Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Affiliate 44
Recent Developments 45
Financial Announcements 45
Nov 08, 2017: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2017 45
Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017 47
May 10, 2017: Hologic Announces Financial Results for Second Quarter of Fiscal 2017 49
Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017 50
Nov 02, 2016: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016 52
Jul 27, 2016: Hologic Announces Financial Results for Third Quarter of Fiscal 2016 54
Apr 27, 2016: Hologic Announces Financial Results for Second Quarter of Fiscal 2016 56
Jan 27, 2016: Hologic Announces Financial Results for First Quarter of Fiscal 2016 57
Corporate Communications 59
May 16, 2017: Charles J. Dockendorff Elected to Hologic Board of Directors 59
Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team 60
Dec 16, 2016: Amy Wendell Elected to Hologic Board of Directors 61
Mar 02, 2016: Chris Coughlin Elected to Hologic Board of Directors 62
Legal and Regulatory 63
Jan 19, 2016: Hologic’s Tepnel Pharma Services Achieves ISO 17025 Accreditation for Extraction and Genotyping Services 63
Product News 64
Jun 29, 2017: Hologic’s New Panther Fusion System, Flu and Respiratory Assays Now CE Marked in Europe 64
Mar 01, 2017: Hologic to Showcase Groundbreaking Breast Cancer Screening and Interventional Solutions at European Congress of Radiology 2017 65
Nov 25, 2016: Hologic to Showcase Award-Winning Breast Screening and Interventional Solutions at RSNA 2016 66
01/06/2016: Metamark Genetics to Serve as Exclusive Sales Agent for Hologic’s Proprietary Prostate Cancer Test 67
Other Significant Developments 68
Aug 09, 2016: HHS awards $4.1 Million to Hologic to Develop better Zika Blood Screening Test 68
Jul 21, 2016: Bovie Medical Announces Sales Channel Partnership Agreement with Hologic for J-Plasma 69
Appendix 70
Methodology 70
About GlobalData 70
Contact Us 70
Disclaimer 70

List of Tables
Hologic Inc, Medical Equipment, Key Facts, 2016 2
Hologic Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Hologic Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Hologic Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Hologic Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Hologic Inc, Deals By Market, 2011 to YTD 2017 9
Hologic Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Hologic Acquires PCA3 Assets from DiagnoCure for USD4.7 Million 12
Percipient Capital Completes Management Buyout Of Elucigene Diagnostics 13
MeVis Medical Enters into Licensing Agreement with Hologic 14
Microsulis Medical Enters Into Licensing Agreement With Hologic 15
Hologic Enters into Development and Distribution Agreement with Clarius Mobile Health 16
Seegene Enters into Agreement with Hologic 17
U.S. Department of Health and Human Services Enters into Agreement with Hologic 18
Bovie Medical Enters into Agreement with Hologic 19
Metamark Genetics Enters into Distribution Agreement with Hologic 20
Metamark Genetics Plans to Enter into Co-Development Agreement with Hologic 21
Medimaps Enters into Distribution Agreement with Hologic for TBS iNsight 22
Quest Diagnostics Enters Into Co-Development Agreement With Hologic 23
Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 24
Hologic Raises USD1 Billion in Private Placement of 5.25% Notes Due 2022 25
Hologic Completes Private Placement Of Senior Notes Due 2020 For US$1 Billion 26
Grifols Acquires Nucleic Acid Testing Donor Screening Unit from Hologic for USD1.85 Billion 27
Immucor Completes Acquisition Of Lifecodes Business Of Hologic For US$95 Million 29
Atossa Genetics Acquires Rights to Microcatheter System from Hologic 31
Hologic Acquires Cynosure in Tender Offer 32
Hologic Completes Acquisition Of Gen-Probe For US$3.7 Billion 34
Hologic Acquires Beijing Healthcome For Up To US$17 Million 36
Hologic Acquires TCT International 37
Hologic Acquires Interlace Medical 38
Hologic Inc, Key Competitors 40
Hologic Inc, Key Employees 41
Hologic Inc, Other Locations 42
Hologic Inc, Subsidiaries 42
Hologic Inc, Affiliate 44

★海外企業調査レポート[Hologic Inc (HOLX)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • JFE Systems, Inc. (4832):企業財務及び戦略的SWOT分析
    Summary JFE Systems, Inc. (JFE Systems) is a technology company that offers integration, operation, and maintenance services. The company plans, designs, develops, operates and maintains business information systems and provides systems integration services. It offers product-based solutions such as …
  • Applied Proteomics, Inc.(製薬・医療分野):企業M&A動向
    Summary Applied Proteomics, Inc. (API) is a biotechnology company. The company develops proteomics platform solution to make protein-based biomarker. It advanced to the application of proteomics for the development of diagnostics, companion diagnostics, and personalized medicine applications leading …
  • Questerre Energy Corporation (QEC):企業財務及び戦略的SWOT分析
    Summary Questerre Energy Corporation (Questerre) is an independent oil and gas company that explores, develops and produces oil and gas from its unconventional oil and gas properties. The company’s unconventional properties comprise tight oil, shale oil and shale gas. Its properties are located in f …
  • Parkson Retail Group Limited:企業の戦略・SWOT・財務分析
    SummaryParkson Retail Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company …
  • Charkit Chemical Corp:戦略・SWOT・企業財務分析
    Charkit Chemical Corp - Strategy, SWOT and Corporate Finance Report Summary Charkit Chemical Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ceragenix Pharmaceuticals, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ceragenix Pharmaceuticals, Inc. …
  • Airgas, Inc.:戦略・SWOT・企業財務分析
    Airgas, Inc. - Strategy, SWOT and Corporate Finance Report Summary Airgas, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Ludwig Institute For Cancer Research Ltd:企業のM&A・提携動向(医療分野)
    Summary Ludwig Institute for Cancer Research Ltd (LICR) is a not-for-profit organization that conducts cancer research and clinical trial programs. The organization holds expertise in patents, licensing, contracts, portfolio development, clinical trials and start up biotech. It carries research in t …
  • Venn Life Sciences Holdings Plc (VENN):企業のM&A・提携動向(医療分野)
    Summary Venn Life Sciences Holdings Plc (Venn Life Sciences), formerly Armscote Investment Company Plc is a contract research company that offers drug development and clinical services. The company’s drug development services comprise clinical development, drug candidate selection, in-licensing and …
  • Royal Dutch Shell Plc (RDSA)-石油・ガス分野:企業M&A・提携分析
    Summary Royal Dutch Shell plc (Shell) is an integrated oil and gas company. The company explores for and produces oil and gas from conventional fields and sources such as tight rock, shale and coal formations. Its refining and petrochemical complexes across the world add value to its upstream produc …
  • ITC Limited (formerly Imperial Tobacco Company of India Limited):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' ITC Limited (formerly Imperial …
  • TenneT TSO GmbH:企業のM&A・提携動向(エネルギー分野)
    Summary TenneT TSO GmbH (TenneT TSO), formerly Transpower Stromubertragungs GmbH, a subsidiary of TenneT Holding B.V. is an electricity transmission system company that administrates and maintain national transmission grid. The company provides power transmission, system services, and facilitates a …
  • Ezaki Glico Co., Ltd.:企業の戦略・SWOT・財務分析
    SummaryEzaki Glico Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • Heart Test Laboratories Inc:企業のM&A・提携動向(医療機器分野)
    Summary Heart Test Laboratories Inc (HTL) is a medical device company that offers cardiac care products. The company develops life saving devices for the coronary arterial disease market. Its product MyoVista is a screening tool used to determine the presence and level of myocardial abnormalities an …
  • ClearFlow, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary ClearFlow, Inc. (ClearFlow) is a medical device company that offers surgical equipment. The company designs, develops, manufactures and markets anti-clogging platform of surgical drainage devices. Its products include urinary catheters, gastrointestinal catheters, and wound drainage. ClearFl …
  • Westar Energy, Inc. (WR)(エネルギー分野):企業M&A動向
    Summary Westar Energy, Inc., (Westar Energy) is a vertically integrated and regulated energy company. The company carries out electricity generation, transmission and distribution to retail customers in Kansas area. It owns and operates diversified fueled generation portfolio, consisting of coal, nu …
  • Havas SA:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Havas SA Mergers and Acquisitio …
  • MitoSciences Inc.(製薬・医療分野):企業M&A動向
    Summary MitoSciences Inc. (MitoSciences) is a diagnostic company. The company develops mitochondrial antibodies and mitochondrial assays. Its products include antibodies, ELISA kits, other assay kits, cell fractionation kits, mitochondria samples, recombinant proteins, instruments, detergents and bu …
  • Dresser-Rand Group Inc. (DRC):企業の財務及び戦略的SWOT分析
    Dresser-Rand Group Inc. (DRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Dorel Industries, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Dorel Industries, Inc. Mergers …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆